ArticleBMC pharmacology & toxicology2024
Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir): a retrospective cohort study.
Qin Yalan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.